SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunoGen, Inc. IMGN

Stock Information for ImmunoGen Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ImmunoGen Inc.

ImmunoGen Reports Recent Progress and Third Quarter 2019 Financial Results
ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2019 Operating Results
ImmunoGen Reports Recent Progress and Second Quarter 2019 Financial Results
ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2019 Operating Results
ImmunoGen Announces Completion of Operational Review
ImmunoGen Reports Recent Progress and First Quarter 2019 Financial Results
ImmunoGen Announces Conference Call to Discuss Its First Quarter 2019 Operating Results
ImmunoGen and Sanofi Amend License Agreements

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.